Загрузка...
A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
Insulin degludec/insulin aspart (IDegAsp; 70 % IDeg and 30 % IAsp) is a soluble combination of two individual insulin analogues in one product, designed to provide mealtime glycaemic control due to the IAsp component and basal glucose-lowering effect from the IDeg component. The pharmacokinetic and...
Сохранить в:
| Опубликовано в: : | Clin Pharmacokinet |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340839/ https://ncbi.nlm.nih.gov/pubmed/27696221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-016-0455-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|